שווי כולל של החברה: 2seventybio.com (TSVT)

2seventy bio, Inc. (TSVT) is developing innovative oncology treatments through partnerships with major pharmaceutical companies. However, fierce competition in the myeloma segment and regulatory barriers, combined with restructuring, are weighing on cash flows. Meanwhile, the business adheres to bioethical norms and environmental standards. This price chart, which assists in the basic valuation of the asset, captures the indicator at .

2seventy bio, Inc. (TSVT) leadership in the commercialization of cell therapy ensures business resilience, which is reflected in the calculated enterprise value. This indicator determines the total cost of acquiring the asset by summing market capitalization and net debt, allowing an investor to assess the actual cost of purchasing the company minus its cash reserves and identify any overpayment.